Targeting choroid plexus epithelia and ventricular ependyma for drug delivery to the central nervous system

BMC Neuroscience

Volumn 12, Issue , 2011, Pages

  Gonzalez, Ana M ^a   Leadbeater, Wendy E ^a   Burg, Michael ^b   Sims, Karen ^a   Terasaki, Tetsuya ^c   Johanson, Conrad E ^d   Stopa, Edward G ^d   Eliceiri, Brian P ^b   Baird, Andrew ^a,b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c TOHOKU UNIVERSITY   (Japan)

^d RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE LIBRARY; SYNTHETIC PEPTIDE; PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BACTERIOPHAGE M13; BIOLOGICAL THERAPY; CENTRAL NERVOUS SYSTEM; CHOROID PLEXUS; DRUG DELIVERY SYSTEM; EPENDYMA; EPITHELIUM CELL; INTERNALIZATION; MALE; NONHUMAN; PROTEIN TARGETING; RAT; ANIMAL; BAGG ALBINO MOUSE; BRAIN VENTRICLE; C57BL MOUSE; CELL CULTURE; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; METABOLISM; METHODOLOGY; MOUSE; SPRAGUE DAWLEY RAT; WISTAR RAT;

ANIMALS; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM; CEREBRAL VENTRICLES; CHOROID PLEXUS; DRUG DELIVERY SYSTEMS; EPENDYMA; EPITHELIAL CELLS; FEMALE; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PEPTIDE LIBRARY; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR;

EID: 78650944148     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-12-4     Document Type: Article

References (77)

1. Bickel U, Yoshikawa T, Pardridge WM. Delivery of peptides and proteins through the blood-brain barrier. Adv Drug Deliv Rev 2001, 46:247-279. 10.1016/S0169-409X(00)00139-3, 11259843.
2. Pardridge WM. Blood-brain barrier delivery. Drug Discov Today 2007, 12:54-61. 10.1016/j.drudis.2006.10.013, 17198973.
3. Brown PD, Davies SL, Speake T, Millar ID. Molecular mechanisms of cerebrospinal fluid production. Neuroscience 2004, 129:957-970. 10.1016/j.neuroscience.2004.07.003, 1890044, 15561411.
4. Greitz D, Hannerz J. A proposed model of cerebrospinal fluid circulation: observations with radionuclide cisternography. AJNR Am J Neuroradiol 1996, 17:431-438.
5. Johanson CE, Duncan JA, Stopa EG, Baird A. Enhanced prospects for drug delivery and brain targeting by the choroid plexus-CSF route. Pharm Res 2005, 22:1011-1037. 10.1007/s11095-005-6039-0, 16028003.
6. Marques F, Sousa JC, Correia-Neves M, Oliveira P, Sousa N, Palha JA. The choroid plexus response to peripheral inflammatory stimulus. Neuroscience 2007, 144:424-430. 10.1016/j.neuroscience.2006.09.029, 17069984.
7. Speake T, Brown PD. Ion channels in epithelial cells of the choroid plexus isolated from the lateral ventricle of rat brain. Brain Res 2004, 1005:60-66. 10.1016/j.brainres.2004.01.034, 15044065.
8. Speake T, Whitwell C, Kajita H, Majid A, Brown PD. Mechanisms of CSF secretion by the choroid plexus. Microsc Res Tech 2001, 52:49-59. 10.1002/1097-0029(20010101)52:1<49::AID-JEMT7>3.0.CO;2-C, 11135448.
9. Stopa EG, Berzin TM, Kim S, Song P, Kuo-LeBlanc V, Rodriguez-Wolf M, Baird A, Johanson CE. Human choroid plexus growth factors: What are the implications for CSF dynamics in Alzheimer's disease?. Exp Neurol 2001, 167:40-47. 10.1006/exnr.2000.7545, 11161591.
10. Veening JG, Barendregt HP. The regulation of brain states by neuroactive substances distributed via the cerebrospinal fluid; a review. Cerebrospinal Fluid Res 2010, 7:1. 10.1186/1743-8454-7-1, 2821375, 20157443.
11. Watanabe Y, Matsumoto N, Dezawa M, Itokazu Y, Yoshihara T, Ide C. Conditioned medium of the primary culture of rat choroid plexus epithelial (modified ependymal) cells enhances neurite outgrowth and survival of hippocampal neurons. Neurosci Lett 2005, 379:158-163. 10.1016/j.neulet.2004.12.068, 15843055.
12. Szmydynger-Chodobska J, Strazielle N, Zink BJ, Ghersi-Egea JF, Chodobski A. The role of the choroid plexus in neutrophil invasion after traumatic brain injury. J Cereb Blood Flow Metab 2009, 29:1503-1516. 10.1038/jcbfm.2009.71, 2736364, 19471279.
13. Strazielle N, Belin MF, Ghersi-Egea JF. Choroid plexus controls brain availability of anti-HIV nucleoside analogs via pharmacologically inhibitable organic anion transporters. AIDS 2003, 17:1473-1485. 10.1097/00002030-200307040-00008, 12824785.
14. Ghersi-Egea JF, Strazielle N. Brain drug delivery, drug metabolism, and multidrug resistance at the choroid plexus. Microsc Res Tech 2001, 52:83-88. 10.1002/1097-0029(20010101)52:1<83::AID-JEMT10>3.0.CO;2-N, 11135451.
15. Burg MA, Jensen-Pergakes K, Gonzalez AM, Ravey P, Baird A, Larocca D. Enhanced phagemid particle gene transfer in camptothecin-treated carcinoma cells. Cancer Res 2002, 62:977-981.
16. Kassner PD, Burg MA, Baird A, Larocca D. Genetic selection of phage engineered for receptor-mediated gene transfer to mammalian cells. Biochem Biophys Res Commun 1999, 264:921-928. 10.1006/bbrc.1999.1603, 10544031.
17. Larocca D, Baird A. Receptor-mediated gene transfer by phage-display vectors: applications in functional genomics and gene therapy. Drug Discov Today 2001, 6:793-801. 10.1016/S1359-6446(01)01837-2, 11470588.
18. Larocca D, Jensen-Pergakes K, Burg MA, Baird A. Gene transfer using targeted filamentous bacteriophage. Methods Mol Biol 2002, 185:393-401.
19. Larocca D, Witte A, Johnson W, Pierce GF, Baird A. Targeting bacteriophage to mammalian cell surface receptors for gene delivery. Hum Gene Ther 1998, 9:2393-2399. 10.1089/hum.1998.9.16-2393, 9829538.
20. Gonzalez AM, Leadbeater W, Podvin S, Borboa A, Burg M, Sawada R, Rayner J, Sims K, Terasaki T, Johanson C, et al. Epidermal growth factor targeting of bacteriophage to the choroid plexus for gene delivery to the central nervous system via cerebrospinal fluid. Brain Res 2010, 1359:1-13. 10.1016/j.brainres.2010.08.044, 20732308.
21. Bajocchi G, Feldman SH, Crystal RG, Mastrangeli A. Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vectors. Nat Genet 1993, 3:229-234. 10.1038/ng0393-229, 8485578.
22. Driesse MJ, Kros JM, Avezaat CJ, Valerio D, Vecht CJ, Bout A, Smitt PA. Distribution of recombinant adenovirus in the cerebrospinal fluid of nonhuman primates. Hum Gene Ther 1999, 10:2347-2354. 10.1089/10430349950016997, 10515454.
23. Herbst RS. Review of epidermal growth factor receptor biology. Int J Radiat Oncol Biol Phys 2004, 59:21-26. 10.1016/j.ijrobp.2003.10.027, 15142631.
24. Laurence DJ, Gusterson BA. The epidermal growth factor. A review of structural and functional relationships in the normal organism and in cancer cells. Tumour Biol 1990, 11:229-261. 10.1159/000217659, 2203137.
25. Burg M, Ravey EP, Gonzales M, Amburn E, Faix PH, Baird A, Larocca D. Selection of internalizing ligand-display phage using rolling circle amplification for phage recovery. DNA Cell Biol 2004, 23:457-462. 10.1089/1044549041474760, 15294095.
26. Smith GP. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 1985, 228:1315-1317. 10.1126/science.4001944, 4001944.
27. Barbas CF. Phage display: a laboratory manual 2001, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
28. Adhya S, Black L, Friedman D, Hatfull G, Kreuzer K, Merril C, Oppenheim A, Rohwer F, Young R. 2004 ASM Conference on the New Phage Biology: the 'Phage Summit'. Mol Microbiol 2005, 55:1300-1314. 10.1111/j.1365-2958.2005.04509.x, 15720541.
29. Muruganandam A, Tanha J, Narang S, Stanimirovic D. Selection of phage-displayed llama single-domain antibodies that transmigrate across human blood-brain barrier endothelium. FASEB J 2002, 16:240-242.
30. Poul MA, Marks JD. Targeted gene delivery to mammalian cells by filamentous bacteriophage. J Mol Biol 1999, 288:203-211. 10.1006/jmbi.1999.2678, 10329137.
31. McMenamin PG. Distribution and phenotype of dendritic cells and resident tissue macrophages in the dura mater, leptomeninges, and choroid plexus of the rat brain as demonstrated in wholemount preparations. J Comp Neurol 1999, 405:553-562. 10.1002/(SICI)1096-9861(19990322)405:4<553::AID-CNE8>3.0.CO;2-6, 10098945.
32. Barry MA, Dower WJ, Johnston SA. Toward cell-targeting gene therapy vectors: selection of cell-binding peptides from random peptide-presenting phage libraries. Nat Med 1996, 2:299-305. 10.1038/nm0396-299, 8612228.
33. Hart SL, Knight AM, Harbottle RP, Mistry A, Hunger HD, Cutler DF, Williamson R, Coutelle C. Cell binding and internalization by filamentous phage displaying a cyclic Arg-Gly-Asp-containing peptide. J Biol Chem 1994, 269:12468-12474.
34. Horst J, Kluge F, Beyreuther K, Gerok W. Gene transfer to human cells: transducing phage lambda plac gene expression in GMI-gangliosidosis fibroblasts. Proc Natl Acad Sci USA 1975, 72:3531-3535. 10.1073/pnas.72.9.3531, 433029, 242006.
35. Ishiura M, Hirose S, Uchida T, Hamada Y, Suzuki Y, Okada Y. Phage particle-mediated gene transfer to cultured mammalian cells. Mol Cell Biol 1982, 2:607-616. 369836, 14582156.
36. Ivanenkov VV, Menon AG. Peptide-mediated transcytosis of phage display vectors in MDCK cells. Biochem Biophys Res Commun 2000, 276:251-257. 10.1006/bbrc.2000.3358, 11006114.
37. Koivunen E, Arap W, Rajotte D, Lahdenranta J, Pasqualini R. Identification of receptor ligands with phage display peptide libraries. J Nucl Med 1999, 40:883-888.
38. Koivunen E, Restel BH, Rajotte D, Lahdenranta J, Hagedorn M, Arap W, Pasqualini R. Integrin-binding peptides derived from phage display libraries. Methods Mol Biol 1999, 129:3-17.
39. Kolonin MG, Saha PK, Chan L, Pasqualini R, Arap W. Reversal of obesity by targeted ablation of adipose tissue. Nat Med 2004, 10:625-632. 10.1038/nm1048, 15133506.
40. Merril CR, Biswas B, Carlton R, Jensen NC, Creed GJ, Zullo S, Adhya S. Long-circulating bacteriophage as antibacterial agents. Proc Natl Acad Sci USA 1996, 93:3188-3192. 10.1073/pnas.93.8.3188, 39580, 8622911.
41. Molenaar TJ, Michon I, de Haas SA, van Berkel TJ, Kuiper J, Biessen EA. Uptake and processing of modified bacteriophage M13 in mice: implications for phage display. Virology 2002, 293:182-191. 10.1006/viro.2001.1254, 11853411.
42. Mount JD, Samoylova TI, Morrison NE, Cox NR, Baker HJ, Petrenko VA. Cell targeted phagemid rescued by preselected landscape phage. Gene 2004, 341:59-65. 10.1016/j.gene.2004.07.006, 15474288.
43. Paillard F. Bacteriophage: tools toward a cell-targeted delivery. Hum Gene Ther 1998, 9:2307-2308. 10.1089/hum.1998.9.16-2307, 9829529.
44. Pasqualini R. Vascular targeting with phage peptide libraries. Q J Nucl Med 1999, 43:159-162.
45. Pasqualini R, Arap W, McDonald DM. Probing the structural and molecular diversity of tumor vasculature. Trends Mol Med 2002, 8:563-571. 10.1016/S1471-4914(02)02429-2, 12470989.
46. Pasqualini R, Ruoslahti E. Searching for a molecular address in the brain. Mol Psychiatry 1996, 1:421-422.
47. Pasqualini R, Ruoslahti E. Tissue targeting with phage peptide libraries. Mol Psychiatry 1996, 1:423.
48. Rajotte D, Arap W, Hagedorn M, Koivunen E, Pasqualini R, Ruoslahti E. Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display. J Clin Invest 1998, 102:430-437. 10.1172/JCI3008, 508902, 9664085.
49. Rakonjac J, Jovanovic G, Model P. Filamentous phage infection-mediated gene expression: construction and propagation of the gIII deletion mutant helper phage R408d3. Gene 1997, 198:99-103. 10.1016/S0378-1119(97)00298-9, 9370269.
50. Trepel M, Arap W, Pasqualini R. Exploring vascular heterogeneity for gene therapy targeting. Gene Ther 2000, 7:2059-2060. 10.1038/sj.gt.3301361, 11223985.
51. Yip YL, Hawkins NJ, Smith G, Ward RL. Biodistribution of filamentous phage-Fab in nude mice. J Immunol Methods 1999, 225:171-178. 10.1016/S0022-1759(99)00044-7, 10365793.
52. Yokoyama-Kobayashi M, Kato S. Recombinant f1 phage-mediated transfection of mammalian cells using lipopolyamine technique. Anal Biochem 1994, 223:130-134. 10.1006/abio.1994.1557, 7695088.
53. Zurita AJ, Arap W, Pasqualini R. Mapping tumor vascular diversity by screening phage display libraries. J Control Release 2003, 91:183-186. 10.1016/S0168-3659(03)00236-0, 12932650.
54. Larocca D, Kassner PD, Witte A, Ladner RC, Pierce GF, Baird A. Gene transfer to mammalian cells using genetically targeted filamentous bacteriophage. FASEB J 1999, 13:727-734.
55. Larocca D, Jensen-Pergakes K, Burg MA, Baird A. Receptor-targeted gene delivery using multivalent phagemid particles. Mol Ther 2001, 3:476-484. 10.1006/mthe.2001.0284, 11319907.
56. Larocca D, Burg MA, Jensen-Pergakes K, Ravey EP, Gonzalez AM, Baird A. Evolving phage vectors for cell targeted gene delivery. Curr Pharm Biotechnol 2002, 3:45-57. 10.2174/1389201023378490, 11883506.
57. Faix PH, Burg MA, Gonzales M, Ravey EP, Baird A, Larocca D. Phage display of cDNA libraries: enrichment of cDNA expression using open reading frame selection. Biotechniques 2004, 36:1018-1022. 1024, 1026-1019.
58. Costantini TW, Putnam JG, Sawada R, Baird A, Loomis WH, Eliceiri BP, Bansal V, Coimbra R. Targeting the gut barrier: identification of a homing peptide sequence for delivery into the injured intestinal epithelial cell. Surgery 2009, 146:206-212. 10.1016/j.surg.2009.05.007, 19628075.
59. Spector R, Johanson C. Micronutrient and urate transport in choroid plexus and kidney: implications for drug therapy. Pharm Res 2006, 23:2515-2524. 10.1007/s11095-006-9091-5, 17048121.
60. Haselbach M, Wegener J, Decker S, Engelbertz C, Galla HJ. Porcine Choroid plexus epithelial cells in culture: regulation of barrier properties and transport processes. Microsc Res Tech 2001, 52:137-152. 10.1002/1097-0029(20010101)52:1<137::AID-JEMT15>3.0.CO;2-J, 11135456.
61. Hakvoort A, Haselbach M, Galla HJ. Active transport properties of porcine choroid plexus cells in culture. Brain Res 1998, 795:247-256. 10.1016/S0006-8993(98)00284-4, 9622643.
62. Herenu CB, Sonntag WE, Morel GR, Portiansky EL, Goya RG. The ependymal route for insulin-like growth factor-1 gene therapy in the brain. Neuroscience 2009, 163:442-447. 10.1016/j.neuroscience.2009.06.024, 2740751, 19531373.
63. Carro E, Trejo JL, Spuch C, Bohl D, Heard JM, Torres-Aleman I. Blockade of the insulin-like growth factor I receptor in the choroid plexus originates Alzheimer's-like neuropathology in rodents: new cues into the human disease?. Neurobiol Aging 2006, 27:1618-1631. 10.1016/j.neurobiolaging.2005.09.039, 16274856.
64. Carro E, Nunez A, Busiguina S, Torres-Aleman I. Circulating insulin-like growth factor I mediates effects of exercise on the brain. J Neurosci 2000, 20:2926-2933.
65. Engelhardt B. The blood-central nervous system barriers actively control immune cell entry into the central nervous system. Curr Pharm Des 2008, 14:1555-1565. 10.2174/138161208784705432, 18673197.
66. Pardridge WM. Drug targeting to the brain. Pharm Res 2007, 24:1733-1744. 10.1007/s11095-007-9324-2, 17554607.
67. Chen YH, Chang M, Davidson BL. Molecular signatures of disease brain endothelia provide new sites for CNS-directed enzyme therapy. Nat Med 2009, 15:1215-1218. 10.1038/nm.2025, 19749771.
68. Rodriguez EM, Blazquez JL, Guerra M. The design of barriers in the hypothalamus allows the median eminence and the arcuate nucleus to enjoy private milieus: the former opens to the portal blood and the latter to the cerebrospinal fluid. Peptides 2010, 31:757-776. 10.1016/j.peptides.2010.01.003, 20093161.
69. Marques F, Sousa JC, Coppola G, Falcao AM, Rodrigues AJ, Geschwind DH, Sousa N, Correia-Neves M, Palha JA. Kinetic profile of the transcriptome changes induced in the choroid plexus by peripheral inflammation. J Cereb Blood Flow Metab 2009, 29:921-932. 10.1038/jcbfm.2009.15, 19240744.
70. Vigh B, Manzano e Silva MJ, Frank CL, Vincze C, Czirok SJ, Szabo A, Lukats A, Szel A. The system of cerebrospinal fluid-contacting neurons. Its supposed role in the nonsynaptic signal transmission of the brain. Histol Histopathol 2004, 19:607-628.
71. Vigh B, Vigh-Teichmann I, Aros B. Special dendritic and axonal endings formed by the cerebrospinal fluid contacting neurons of the spinal cord. Cell Tissue Res 1977, 183:541-552. 10.1007/BF00225666, 922853.
72. Vigh B, Vigh-Teichmann I, Manzano e Silva MJ, van den Pol AN. Cerebrospinal fluid-contacting neurons of the central canal and terminal ventricle in various vertebrates. Cell Tissue Res 1983, 231:615-621. 10.1007/BF00218119, 6871973.
73. Gleason D, Fallon JH, Guerra M, Liu JC, Bryant PJ. Ependymal stem cells divide asymmetrically and transfer progeny into the subventricular zone when activated by injury. Neuroscience 2008, 156:81-88. 10.1016/j.neuroscience.2008.06.065, 18682279.
74. Kazanis I. The subependymal zone neurogenic niche: a beating heart in the centre of the brain: how plastic is adult neurogenesis? Opportunities for therapy and questions to be addressed. Brain 2009, 132:2909-2921. 10.1093/brain/awp237, 2768664, 19773354.
75. Regev L, Ezrielev E, Gershon E, Gil S, Chen A. Genetic approach for intracerebroventricular delivery. Proc Natl Acad Sci USA 2010, 107:4424-4429. 10.1073/pnas.0907059107, 2840118, 20142482.
76. Aida Y, Pabst MJ. Removal of endotoxin from protein solutions by phase separation using Triton X-114. J Immunol Methods 1990, 132:191-195. 10.1016/0022-1759(90)90029-U, 2170533.
77. Kitazawa T, Hosoya K, Watanabe M, Takashima T, Ohtsuki S, Takanaga H, Ueda M, Yanai N, Obinata M, Terasaki T. Characterization of the amino acid transport of new immortalized choroid plexus epithelial cell lines: a novel in vitro system for investigating transport functions at the blood-cerebrospinal fluid barrier. Pharm Res 2001, 18:16-22. 10.1023/A:1011014424212, 11336348.